CIBC Private Wealth Group’s PAVmed PAVM Stock Holding History

CIBC Private Wealth Group’s Portfolio PAVM Stock Details PAVM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$185	Hold	28	–	–	﹤0.01%	3231
2025 Q3	$360	Hold	28	–	–	﹤0.01%	2908
2025 Q2	$502	Hold	28	–	–	﹤0.01%	2842
2025 Q1	$503	Hold	28	–	–	﹤0.01%	2892
2024 Q4	$518	Hold	28	–	–	﹤0.01%	2847
2024 Q3	$1.03K	Hold	28	–	–	﹤0.01%	2906
2024 Q2	$664	Hold	28	–	–	﹤0.01%	2948
2024 Q1	$1.71K	Buy	+28	New	+$2.12K	﹤0.01%	2779
2023 Q4	–	Sell	-28	Closed	-$3.69K	–	1173
2023 Q3	$3.69K	Hold	28	–	–	﹤0.01%	1075
2023 Q2	$5.11K	Hold	28	–	–	﹤0.01%	874
2023 Q1	$4.68K	Hold	28	–	–	﹤0.01%	884
2022 Q4	$6	Hold	28	–	–	﹤0.01%	856
2022 Q3	$11K	Hold	28	–	–	﹤0.01%	905
2022 Q2	$12K	Hold	28	–	–	﹤0.01%	1057
2022 Q1	$17K	Hold	28	–	–	﹤0.01%	1114
2021 Q4	$31K	Buy	+28	New	+$60.9K	﹤0.01%	1004
2021 Q3	–	Sell	-56	Closed	-$160K	–	1000
2021 Q2	$160K	Sell	56 -25	-31%	-$59.1K	﹤0.01%	1006
2021 Q1	$162K	Hold	81	–	–	﹤0.01%	1003
2020 Q4	$77K	Hold	81	–	–	﹤0.01%	967
2020 Q3	$77K	Buy	+81	New	+$72.1K	﹤0.01%	863

Other funds holding PAVM

First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

CAPTRUST Financial Advisors Raleigh, North Carolina $57.3B AUM 18.32% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

CIBC Private Wealth Group's PAVM Position: Q4 2025 in Review

CIBC Private Wealth Group held its PAVmed (PAVM) position steady in Q4 2025 at 28 shares worth $185. The position accounts for ﹤0.01% of the portfolio, ranked #3231.

CIBC Private Wealth Group first reported a position in PAVM in Q3 2020 and has held it in 20 quarters since. The position peaked at $162K in Q1 2021. 28 funds tracked by Wall St. Rank hold PAVM as of Q4 2025.

CIBC Private Wealth Group held 28 shares of PAVmed worth $185 as of Q4 2025.
CIBC Private Wealth Group left its PAVmed share count unchanged in Q4 2025.
PAVmed made up ﹤0.01% of CIBC Private Wealth Group's portfolio in Q4 2025, its #3231 holding.
CIBC Private Wealth Group first reported a position in PAVmed in Q3 2020 and has held it in 20 quarters since.
CIBC Private Wealth Group's PAVmed position peaked at $162K in Q1 2021.
28 funds tracked by Wall St. Rank held PAVmed as of Q4 2025.

Based on CIBC Private Wealth Group's 13F filing for Q4 2025, filed 12 Feb 2026.